Chanakya Kodishala Jun 2026
One of Dr. Kodishala's most prominent areas of study is examining how Rheumatoid Arthritis (RA) affects the brain. Historically, RA was viewed primarily as a joint disease. However, work co-authored by Dr. Kodishala emphasizes that systemic inflammation can accelerate cognitive decline.
The curriculum at Chanakya Kodishala was designed to be comprehensive and eclectic, reflecting the diverse interests of its founder. The institution offered a range of courses, including:
Under the guidance of the sage and the esteemed faculty, Rohan and his companions delved into the mysteries of coding theory, computer science, and the ancient Indian philosophy that underpinned it all. They studied the works of Chanakya, the legendary Indian polymath who had founded the Kodishala centuries ago.
In the heart of ancient India, hidden away from prying eyes, lay a mystical institution known as the Chanakya Kodishala. This revered school was dedicated to imparting the ancient wisdom of coding and computer science to a select few. For centuries, the Kodishala had been shrouded in mystery, with whispers of its existence sparking curiosity and debate among scholars and enthusiasts alike. Chanakya Kodishala
: Because cardiovascular disease is a significant risk factor for cognitive issues in RA patients, keeping your blood pressure and cholesterol in check is a "two-for-one" win for your heart and your head. Keep Moving (Gently)
Dr. Kodishala has contributed to specialized studies investigating the pathology of cerebrovascular diseases in patients with rheumatoid arthritis. This research helps understand the exact mechanisms (e.g., small vessel disease) that link autoimmunity to brain health. 3. Collaborative Contributions and Impact
A pivotal phase of Dr. Kodishala's career was his appointment as a . At Mayo Clinic, he focused on "identifying the risk factors for cognitive dysfunction in patients with rheumatoid arthritis," contributing to a growing body of knowledge regarding the extra-articular manifestations of RA. One of Dr
Chanakya Kodishala, MBBS, DM, is a prominent rheumatologist and researcher whose work has significantly advanced our understanding of systemic autoimmune diseases and their complex comorbidities. Currently affiliated with the Mayo Clinic's Division of Rheumatology , Kodishala has authored numerous high-impact studies focusing on the intersection of inflammatory conditions and long-term health risks like dementia and cardiovascular disease. Research Focus: The RA-Dementia Connection
His research primarily focuses on aging and rheumatic diseases, with a specific interest in the intersection of physical and cognitive health. Key areas of his published work include: Chanakya Kodishala - Google Scholar
: Dr. Kodishala graduated from Bangalore Medical College and Research Institute in 2010 . He completed his initial training in internal medicine and rheumatology in India before pursuing further medical certifications in the United States . However, work co-authored by Dr
Published in The Journal of Rheumatology , this population-based cohort study is one of his most cited works. The research aimed to identify risk factors for dementia in RA patients and has been discussed in subsequent correspondence.
As we look toward the next five years, the role of the "Digital Strategist" will become as important as the director on a movie set. Chanakya Kodishala is pioneering that transition. He represents a new wave of Indian entrepreneurs who are proving that you don’t need to be in Mumbai (Bollywood) to set national trends.
A: He is best known for his work in B2B digital lending infrastructure, specifically creating APIs for embedded finance and alternative credit scoring models for India’s MSME sector.
He is currently an Internal Medicine resident at the Canton Medical Education Foundation in Ohio, USA.
One of his major focus areas involves analyzing how systemic inflammation affects the brain over time. Through long-term population-based cohort studies, Dr. Kodishala and his co-researchers at the Mayo Clinic have unraveled how rheumatoid arthritis (RA) correlates with Alzheimer's disease and related dementias (AD/ADRD).